Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Accounts Payable & Accrued Expense : ¥2,495 Mil (As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Zhejiang Huahai Pharmaceutical Co Accounts Payable & Accrued Expense?

Zhejiang Huahai Pharmaceutical Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥2,341 Mil) to Dec. 2023 (¥2,467 Mil) and increased from Dec. 2023 (¥2,467 Mil) to Mar. 2024 (¥2,495 Mil).

Zhejiang Huahai Pharmaceutical Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥2,093 Mil) to Dec. 2022 (¥2,552 Mil) but then declined from Dec. 2022 (¥2,552 Mil) to Dec. 2023 (¥2,467 Mil).

Zhejiang Huahai Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Zhejiang Huahai Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Huahai Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Zhejiang Huahai Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,121.34

1,719.66

2,093.36

2,551.77

2,467.23

Zhejiang Huahai Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															2,255.63	2,392.84	2,341.27	2,467.23	2,494.97

Zhejiang Huahai Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Huahai Pharmaceutical Co Ltd (SHSE:600521) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

Economic Development Zone, Xunqiao Town, Linhai, Taizhou, Zhejiang, CHN, 317024

Website

http://www.huahaipharm.com

Zhejiang Huahai Pharmaceutical Co Ltd provides formulations, active pharmaceutical ingredients, and intermediates in China and internationally. The company also offers pril products, including captopril, enalapril, and lisinopril.

Executives

Chen Bao Hua	Director
Shang Fei	senior management
Du Jun	Director
Su Yan	Director
Chen Dun Yuan	senior management
Li Hong	Director
Guo Si Jia	senior management
Li Min	senior management
Xu Bo	senior management
Wang Jie	senior management
Chen Qi Mao	senior management
Zhang Hong	senior management
Zhang Mei	senior management
Zhu Yong Hua	Directors, senior managers
Wang Yi Hua	senior management

Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Headlines

No Headlines